enVVeno Medical CorporationNVNONASDAQ
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
30.30%
↑ 454% above average
Average (39q)
-8.56%
Historical baseline
Range
High:88.16%
Low:-207.69%
Volatility
-3455.3%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 30.30% |
| Q2 2025 | -50.00% |
| Q1 2025 | 29.03% |
| Q4 2024 | 11.43% |
| Q3 2024 | -12.90% |
| Q2 2024 | 0.00% |
| Q1 2024 | 26.19% |
| Q4 2023 | 6.67% |
| Q3 2023 | 22.41% |
| Q2 2023 | -1.75% |
| Q1 2023 | 12.31% |
| Q4 2022 | -20.37% |
| Q3 2022 | 14.29% |
| Q2 2022 | -34.04% |
| Q1 2022 | 41.25% |
| Q4 2021 | -207.69% |
| Q3 2021 | 7.14% |
| Q2 2021 | 41.67% |
| Q1 2021 | 76.81% |
| Q4 2020 | -50.00% |
| Q3 2020 | 26.98% |
| Q2 2020 | -20.38% |
| Q1 2020 | 50.78% |
| Q4 2019 | -26.09% |
| Q3 2019 | 22.87% |
| Q2 2019 | -2.18% |
| Q1 2019 | 15.30% |
| Q4 2018 | -21.09% |
| Q3 2018 | 88.16% |
| Q2 2018 | -126.09% |
| Q1 2018 | -45.04% |
| Q4 2017 | -31.70% |
| Q3 2017 | -96.78% |
| Q2 2017 | -7.99% |
| Q1 2017 | 19.10% |
| Q4 2016 | -45.31% |
| Q3 2016 | 62.31% |
| Q2 2016 | 0.00% |
| Q1 2016 | -148.09% |
| Q4 2015 | 0.00% |